DANI SpA and JEOL BV have announced that they will be entering into an exclusive distribution agreement involving high-level GC systems and attachments.
DANI SpA and JEOL BV have announced that they will be entering into an exclusive distribution agreement involving high-level GC systems and attachments. DANI offers high throughput GC-TOF, which, according to the companies, will allow them to offer a complete range of GC–MS systems. Additionally, the companies report that the high resolution GC offerings from JEOL will allow them to offer the GC market a more flexible choice.
The companies claim that the combination with GCxGC on every GC-TOF system will open possibilities in a wide variety of applications such as fragrances, environmental research, petrochemical research, quality control and food research.
Dr Umberto Saini from DANI and Dr Bob Hertsens from JEOL say that they are looking forward to expanding their market share with this strategic agreement.
Further information can be found on www.danispa.it and www.jeolbenelux.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
LC/MS Based Characterization Workflow of GLP-1 Therapeutic Peptide Liraglutide and Its Impurities
January 14th 2025This application note demonstrates a liquid chromatography/quadrupole time-of-flight mass spectrometer (LC/Q-TOF MS) workflow for the identification and characterization of therapeutic peptides.